2-methyl- propanenitrileIdentifiersCAS number 120511-73-1ATC code L02BG03PubChem 2187DrugBank APRD00016Chemical dataFormula C17H19N5Mol. mass 293.366 g/molSMILES arimidex testosterone & PubChemPharmacokinetic dataBioavailability 83-85%Protein binding 40%Metabolism 85% hepaticHalf life 72 hoursExcretion 11% renalTherapeutic.

dataFormula C17H19N5Mol. mass 293.366 g/molSMILES eMolecules & arimidex testosterone dataBioavailability arimidex testosterone binding 40%Metabolism 85% hepaticHalf life 72 hoursExcretion 11% renalTherapeutic considerationsPregnancy cat. ?Legal status Rx only arimidex testosterone oralAnastrozole (INN, arimidex testosterone arimidex testosterone Arimidex®) is a drug indicated in the off-label use of reducing estrogens (in particular and more importantly, estradiol) in men. Excess estradiol in men can cause benign prostatic hyperplasia, gynecomastia, and symptoms of hypogonadism. Some athletes and body builders will also use anastrozole as a part of their steroid cycle to reduce and prevent symptoms of excess estrogens; in particular, gynecomastia and water retention.Study data currently suggests that dosages of 0.5mg to 1mg a day reduce serum estradiol by about arimidex testosterone in men, which differs arimidex testosterone the typical reduction in postmenopausal women. However the reduction may be arimidex testosterone for men with grossly elevated estradiol (clinical.

treatment for breast cancer". Lancet 365 (9453): 60-2. doi:10.1016/S0140-6736(04)17666-6. PMID 15639680.[edit] External.